|
|
|
Insider
Information: |
Zaderej Karen L. |
Relationship: |
|
City: |
Alachua |
State: |
FL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
1,208,135 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$7,812,976 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,208,135 |
|
|
Total
Value |
$7,812,976 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-18.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Axogen Inc |
AXGN |
CEO, Director |
2024-03-21 |
1,143,788 |
|
0 |
Premium* |
|
Vive Medical Inc |
VIVE |
Director |
2019-07-01 |
62,347 |
2018-10-01 |
0 |
Premium* |
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
2023-07-11 |
2,000 |
2023-07-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AXGN |
Axogen Inc |
President and CEOOfficer |
|
2011-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
43,049 |
|
- |
|
AXGN |
Axogen Inc |
Chief Executive Officer |
|
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
135,374 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2016-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
282,147 |
0 |
- |
|
VIVE |
Vive Medical Inc |
Director |
|
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
746 |
746 |
0 |
- |
|
VIVE |
Vive Medical Inc |
Director |
|
2018-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,524 |
10,270 |
0 |
- |
|
VIVE |
Vive Medical Inc |
Director |
|
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,248 |
24,518 |
0 |
- |
|
VIVE |
Vive Medical Inc |
Director |
|
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
37,829 |
62,347 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2019-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
599,530 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2020-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
632,792 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
29,993 |
647,244 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,125 |
647,994 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2020-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,800 |
677,599 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
29,999 |
634,916 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2021-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
22,077 |
788,830 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2021-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
924,272 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2021-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,400 |
927,429 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,978 |
940,383 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2022-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,950 |
966,333 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2022-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
22,076 |
988,409 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2022-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,400 |
1,012,695 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2023-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,975 |
1,050,670 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
|
|
2023-07-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2023-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
22,076 |
1,072,746 |
0 |
- |
|
AXGN |
Axogen Inc |
CEO |
|
2024-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
110,322 |
1,146,954 |
0 |
- |
|
AXGN |
Axogen Inc |
Chief Executive Officer |
|
2011-12-19 |
4 |
OE |
$0.27 |
$20,720 |
D/D |
76,741 |
119,790 |
0 |
- |
|
64 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|